Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Pathogenic bacteria Stories

2013-04-23 14:27:21

Our gut is home to trillions of bacteria, numbering more than the cells in the rest of our body, and these bacteria help us to digest our food, absorb nutrients and strengthen our immune system. This complex bacterial ecosystem, called the gut microbiota, also helps to prevent bad bacteria from colonizing our bodies and making us ill. As part of the symbiotic relationship between the gut microbiota and our bodies, the bacteria derive nutrition from our food and convert it into compounds...

2013-03-20 08:26:34

TreatMyUTI.com is offering patients the first online access to physician diagnosis and treatment of uncomplicated urinary tract infections. No office visit, examination, or lab testing is required. COLUMBIA, S.C., March 20, 2013 /PRNewswire/ -- TreatMyUTI.com was founded by a group of like-minded physicians who recognize that, in today's evolving world of healthcare, an emphasis will be placed on treatment plans that are safe, efficient, and cost effective. This plan of diagnosis...

2013-03-14 08:29:01

Replikins Synthetic Vaccines Against Antibiotic-Resistant Gonococcus, Tuberculosis, Staphylococcus, Streptococcus, Klebsiella KPC, and Cl. Difficile OTTAWA, Ontario, March 14, 2013 /PRNewswire/ -- A group of lethal bacteria are of increasing concern worldwide because they are becoming resistant to many or all of the antibiotics previously effective against them (1). Bioradar UK Ltd. announced today in Ottawa, Canada that it has discovered that the concentration of genomic Replikins...

2013-03-14 00:20:49

AUSTIN, TX and TORONTO, March 13, 2013 /PRNewswire/ - Affinium Pharmaceuticals announced today the expansion of its leadership team with the appointment of two senior biotech and pharmaceutical executives to its leadership team:  Ed Mascioli, M.D. is appointed Chief Executive Officer (CEO), and Mr. Robert (Bob) Radie is appointed to the Board of Directors. Dr. Mascioli is an experienced pharmaceutical and venture executive, and held prior positions as a senior executive at...

Antibiotic-Resistant Bacterial Infections On The Rise, CDC Warns
2013-03-06 08:32:36

Lawrence LeBlond for redOrbit.com - Your Universe Online While bacterial infections are a relatively common occurrence throughout US hospitals, federal health officials have warned they are on the rise and becoming more resilient, and are urging all healthcare facilities around the country to be on guard. The US Centers for Disease Control and Prevention (CDC) released its new Vital Signs report on Tuesday, reporting that so-called carbapenem-resistant Enterobacteriaceae (CRE)...

2013-02-28 08:29:52

Blood Culture Systems Comparison Study Shows BD BACTEC(TM) Plus Aerobic Medium Provides Statistically Significant Differences in Bacterial Recovery for Patients on Antimicrobial Therapy BALTIMORE, Feb. 28, 2013 /PRNewswire/ -- A new study, published in the journal Clinical Infectious Diseases, demonstrates how treatment with broad-spectrum antibiotics can impact the ability to detect bacteria in blood samples from potentially septic patients. It also highlights the importance of...

2013-02-20 23:02:25

New evidence shows that the cause of chronic sinusitis if often Staphylococcus aureus, a difficult bacteria to treat. Hydro Med suggests a natural way to reduce bacteria count to enable natural healing. Mission Hills, Ca. (PRWEB) February 20, 2013 Why do thirty five million persons in the U.S. have chronic sinusitis, despite modern technologies and drugs? Why are there so many treatment failures? The answer is that a nasty bug is the cause. At the International Forum of Allergy and...

2013-02-12 08:30:10

CHAPEL HILL, N.C., Feb. 12, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that the National Institute of Allergy and Infectious Diseases (NIAID) awarded a grant to Richard C. Boucher, M.D., Kenan Professor of Medicine and director of the Cystic Fibrosis and Pulmonary Research and Treatment Center at the...

Combining Synthetic And Natural Toxins Could Disarm Cancer And Drug-resistant Bacteria
2013-02-12 08:22:35

Rice University Cancer researchers from Rice University suggest that a new man-made drug that's already proven effective at killing cancer and drug-resistant bacteria could best deliver its knockout blow when used in combination with drugs made from naturally occurring toxins. "One of the oldest tricks in fighting is the one-two punch -- you distract your opponent with one attack and deliver a knockout blow with another," said José Onuchic of Rice's Center for Theoretical...

2013-02-11 10:53:15

National Institutes of Health (NIH) scientists have identified a promising lead for developing a new type of drug to treat infection caused by Staphylococcus aureus, a bacterium that frequently resists traditional antibiotics. The researchers discovered a system used by S. aureus to transport toxins that are thought to contribute to severe staph infections. These toxins–called phenol-soluble modulins (PSMs)–have gained much attention in recent years, but their multitude and...


Latest Pathogenic bacteria Reference Libraries

0_9fb0173be70876d98667eddc1e274866
2011-04-28 14:27:08

Streptococcus pneumoniae, or pneumococcus, is Gram-positive, alpha-hemolytic, bile-soluble aerotolerant, anaerobic member of the genus Streptococcus. It was recognized as a major cause of pneumonia in the late 19th century and is thus the subject of many humoral immunity studies. It causes many other types of pneumococcal infections other than pneumonia including acute sinusitis, otitis media, meningitis, bacteremia, sepsis, septic arthritis, peritonitis, cellulites, and brain abscess. It...

0_565be8ac4669df235cfa9eb09fa14a3d
2011-04-26 20:59:00

Staphylococcus epidermidis is one of thirty-three known species belonging to the genus Staphylococcus. It is part of our skin flora and can also be found in the mucous membranes and in animals. It is the most common species found in laboratory test due to contamination. It is not usually pathogenic; however, patients with a compromised immune system often risk infection. Infections can be both nosocomial and community acquired and are more of a threat to hospital patients. Hospitals carry...

72_eee8f4e550996ac6ae01af15eddb314c
2011-04-26 20:20:41

Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...

72_63ad42c17b548b76aff6af345a402a04
2011-04-15 15:26:30

Haemophilus influenzae is a Gram-negative, rod-shaped bacterium first described in 1892 by Richard Pfeiffer during an influenza pandemic. It is generally aerobic but can grow as a facultative anaerobe. H. influenzae was mistakenly considered to be the cause of influenza until 1933 when the flu virology became apparent. It was the first free-living organism to have its entire genome sequenced. The project was completed and published in 1995. Two major categories were defined: the...

72_04c5b3879bb85672771defa94bb4ac91
2011-04-15 14:54:29

Escherichia coli is a Gram-negative rod-shaped bacterium that is commonly found in the lower intestine of warm-blooded organisms. Most strains are harmless; however, some such as O157:H7 can cause food poisoning in humans and are often responsible for product recalls. The normal flora of the gut normally contains the harmless strains and often provide K2 to the body. They are not always confined to the intestine and have the ability to survive briefly outside of the body. It grows easily...

More Articles (6 articles) »